CYTH
Cyclo Therapeutics, Inc. Common Stock
CYTH
CYTH
Delisted
CYTH was delisted on the 25th of March, 2025.
13 hedge funds and large institutions have $1.38M invested in Cyclo Therapeutics, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
13
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$30K | |
| 2 | +$13.9K | |
| 3 | +$5.89K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.65K |
| 5 |
Citigroup
New York
|
+$4K |
Top Sellers
| 1 | -$83K | |
| 2 | -$38K | |
| 3 | -$32.4K | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$3K |
| 5 |
Morgan Stanley
New York
|
-$1.19K |